NeuLogiq Platform Deployment
Central Nervous System (CNS) Disorders (e.g., Alzheimer's, other dementias, depression)
N/A (Diagnostic/Measurement Platform)Active
Key Facts
Indication
Central Nervous System (CNS) Disorders (e.g., Alzheimer's, other dementias, depression)
Phase
N/A (Diagnostic/Measurement Platform)
Status
Active
Company
About Cumulus Neuroscience
Cumulus Neuroscience is a private, Belfast-based company providing a sophisticated digital biomarker platform for central nervous system (CNS) disorders. Its core product, NeuLogiq®, combines a proprietary EEG headset, validated digital cognitive tasks, and machine learning analytics to enable frequent, at-home, longitudinal monitoring of patients in clinical trials and healthcare settings. The company operates a platform-as-a-service business model, targeting pharmaceutical partners to improve trial efficiency and outcome measurement, and is supported by a unique paid-in Pharma Advisory Group (CPAG) consortium.
View full company profile